---
access_model:
  confidence: low
  label: Unknown
  onboarding: unknown
  pricing: unknown
  public: false
  source:
  - security
  trial: false
  try_now: false
api_count: 0
artifact_total: 1
common:
- group: auth
  title: ''
  type: DomainSecurity
  url: security/onkure-therapeutics-domain-security.yml
- group: company
  title: ''
  type: Website
  url: https://onkuretherapeutics.com/
- group: company
  title: ''
  type: About
  url: https://onkuretherapeutics.com/about/company/
- group: operate
  title: ''
  type: Support
  url: https://onkuretherapeutics.com/contact/
- group: commercial
  title: ''
  type: TermsOfService
  url: https://onkuretherapeutics.com/terms-of-use/
- group: commercial
  title: ''
  type: PrivacyPolicy
  url: https://onkuretherapeutics.com/privacy-policy/
- group: company
  title: ''
  type: InvestorRelations
  url: https://investors.onkuretherapeutics.com/
- group: company
  title: ''
  type: News
  url: https://investors.onkuretherapeutics.com/news-events/news-releases
- group: company
  title: ''
  type: LinkedIn
  url: https://www.linkedin.com/company/onkure-tx/
- group: company
  title: ''
  type: Twitter
  url: https://twitter.com/OnKureTx
- group: agent
  title: ''
  type: WellKnown-Probe
  url: well-known/onkure-therapeutics-well-known.yml
coverage:
  checked: '2026-08-26'
  detail: 'OnKure is a clinical-stage biopharmaceutical company whose product is a drug candidate (OKI-219), not software: its onkuretherapeutics.com site is a WordPress marketing presence with only About/Pipeline/Careers/Contact sections, the sole machine-readable surface is the default WordPress /wp-json/ CMS endpoint exposing Yoast, Wordfence and Redirection plugin routes rather than any OnKure API, and api/developer/docs/graphql/mcp subdomains do not resolve in DNS.'
  evidence:
  - status: 404
    url: https://onkuretherapeutics.com/openapi.json
  - status: 404
    url: https://onkuretherapeutics.com/.well-known/agent-card.json
  - status: 404
    url: https://onkuretherapeutics.com/llms.txt
  - status: 0
    url: https://api.onkuretherapeutics.com/openapi.json
  - status: 200
    url: https://onkuretherapeutics.com/wp-json/
  reason: not-a-software-company
  state: none
created: '2026-08-26'
description: 'OnKure Therapeutics (Nasdaq: OKUR) is a publicly traded, clinical-stage biopharmaceutical company headquartered in Boulder, Colorado, developing precision medicines for people with cancer. The company designs mutant-selective small-molecule inhibitors against oncogenic drivers in the PI3K pathway; its lead program OKI-219 is a selective PI3K-alpha H1047R inhibitor in clinical development, with additional discovery programs targeting further PI3K-alpha mutations. OnKure became publicly listed through its 2024 combination with Reneo Pharmaceuticals. It is a therapeutics developer rather than a software vendor: it operates a corporate and investor relations web presence and publishes no developer program, public API, SDK, or machine-readable API contract.'
image: https://onkuretherapeutics.com/wp-content/uploads/logo-onkure-color-min.png
layout: provider
modified: '2026-08-26'
name: OnKure Therapeutics
nav: Providers
network: true
overview: 'OnKure Therapeutics is profiled on the [APIs.io](https://apis.io/) network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Precision Medicine.


  OnKure Therapeutics'' developer surface includes support, product news, and 9 more developer resources.'
random_paper: 7
screenshot: https://raw.githubusercontent.com/api-evangelist/onkure-therapeutics/refs/heads/main/screenshots/onkure-therapeutics-2026-09-02T150847.png
security:
- kind: domain-security
  name: Onkure Therapeutics Domain Security
  slug: onkure-therapeutics-domain-security
  summary_line: TLSv1.3 · DMARC
slug: onkure-therapeutics
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Clinical Trials
- Life Sciences
- Drug Discovery
- Publicly Traded
website: https://onkuretherapeutics.com/
---
